The Movember Foundation, the Ontario Institute for Cancer Research and Prostate Cancer Canada announced $3 million in funding for a new Phase III clinical trial to evaluate if magnetic resonance imaging (MRI) can replace the current standard of care to diagnose prostate cancer. The primary objective is to determine whether MRI imaging can spare some men from undergoing a biopsy and avoid the possible associated side effects.

The trial will be led by Dr. Laurence Klotz of the Sunnybrook Research Institute in Toronto.

Read the article.

Leave a Comment

Scroll to Top